全球马匹保健市场规模、份额、趋势和成长分析报告（2026-2034）

预计马匹保健市场将从 2025 年的 28.7 亿美元成长到 2034 年的 54.5 亿美元，2026 年至 2034 年的复合年增长率为 7.39%。

随着马匹健康和兽医护理的重要性日益凸显，全球马匹医疗保健市场正蓬勃发展。马匹广泛应用于运动、赛马、农业和休閒娱乐活动，因此，马匹的健康管理成为马主和驯马师的首要任务。马匹兽医诊所的增加以及人们对预防医学实践意识提升，正在推动对先进马匹医疗保健产品和服务的需求。

推动市场发展的关键因素包括专为马匹设计的疫苗、诊断工具、营养补充剂和药物日益普及的现象。兽医专业人员正致力于预防保健和疾病早期检测，以维持马匹的健康与表现。此外，兽医诊断技术和治疗方法的进步也提升了马匹医疗保健服务的整体品质。

未来几年，受全球马术运动和休閒活动蓬勃发展的推动，全球马匹医疗保健市场预计将持续成长。兽医基础设施和研究投入的增加，正助力开发创新马匹医疗保健解决方案。随着马主日益重视马匹的健康和福利，对专业马匹医疗保健服务的需求也将随之增长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球马匹保健市场：依产品划分

• 市场分析、洞察与预测
• 药物分类（抗感染剂、抗发炎药、驱虫药、其他）
• 疫苗（灭活疫苗、减毒活病毒疫苗、重组疫苗等）
• 饲料添加剂

第五章 全球马匹保健市场：依疾病类型划分

• 市场分析、洞察与预测
• 西尼罗病毒
• 马狂犬病
• 马流感
• 马疱疹病毒
• 波托马克河马热
• 破伤风
• 其他的

第六章：全球马匹保健市场：依通路划分

• 市场分析、洞察与预测
• 兽医医院和诊所
• 零售药局和药房
• 其他的

第七章 全球马匹保健市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis Inc
  • Ceva SantAfA（C）Animale
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Vetoquinol
  • Neogen Corporation
  • Virbac
  • Merck & Co. Inc
  • Norbrook Laboratories Ltd
  • Purina Animal Nutrition LLC
  • Kyoritsuseiyaku Corporation
  • Equine Products UK Ltd

The Equine Healthcare Market size is expected to reach USD 5.45 Billion in 2034 from USD 2.87 Billion (2025) growing at a CAGR of 7.39% during 2026-2034.

The Global Equine Healthcare Market is gaining momentum as the importance of horse health and veterinary care continues to increase. Horses are widely used in sports, racing, agriculture, and recreational activities, making their health management a priority for owners and trainers. The rising number of equine veterinary clinics and improved awareness of preventive healthcare practices are driving the demand for advanced equine healthcare products and services.

Key market drivers include the increasing adoption of vaccines, diagnostic tools, nutritional supplements, and pharmaceutical treatments designed specifically for horses. Veterinary professionals are focusing on preventive care and early disease detection to maintain the performance and well-being of horses. Additionally, technological advancements in veterinary diagnostics and treatment methods are improving the overall quality of equine healthcare services.

In the coming years, the Global Equine Healthcare Market is expected to expand as equine sports and recreational activities continue to grow worldwide. Increased investment in veterinary infrastructure and research is supporting the development of innovative healthcare solutions for horses. As horse owners increasingly prioritize animal health and welfare, the demand for specialized equine healthcare services is likely to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others)
• Vaccines (Inactivated, Live Attenuated, Recombinant, Others)
• Supplemental Feed Additives

By Disease Type

• West Nile Virus
• Equine Rabies
• Equine Influenza
• Equine Herpes Virus
• Potomac Horse Fever
• Tetanus
• Others

By Distribution Channel

• Veterinary Hospitals And Clinics
• Retail Pharmacies And Drug Stores
• Others

COMPANIES PROFILED

• Zoetis Inc, Ceva Sant Animale, Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Vetoquinol, Neogen Corporation, Virbac, Merck Co Inc, Norbrook Laboratories Ltd, Purina Animal Nutrition LLC, Kyoritsuseiyaku Corporation, Equine Products UK Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EQUINE HEALTHCARE MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Drug Class (Anti-Infective, Anti-Inflammatory, Parasiticides, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines (Inactivated, Live Attenuated, Recombinant, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Supplemental Feed Additives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EQUINE HEALTHCARE MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. West Nile Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Equine Rabies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Equine Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Equine Herpes Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Potomac Horse Fever Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Tetanus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EQUINE HEALTHCARE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Veterinary Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies And Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EQUINE HEALTHCARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Disease Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Disease Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Disease Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Disease Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Disease Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL EQUINE HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zoetis Inc
  • 9.2.2 Ceva SantAfA(C) Animale
  • 9.2.3 Elanco Animal Health Incorporated
  • 9.2.4 Boehringer Ingelheim International GmbH
  • 9.2.5 Vetoquinol
  • 9.2.6 Neogen Corporation
  • 9.2.7 Virbac
  • 9.2.8 Merck & Co. Inc
  • 9.2.9 Norbrook Laboratories Ltd
  • 9.2.10 Purina Animal Nutrition LLC
  • 9.2.11 Kyoritsuseiyaku Corporation
  • 9.2.12 Equine Products UK Ltd